Navidea forms joint venture with rheumatology startup to target arthritis drugs

Story excerpt provided by Columbus Business First.

Written by Carrie Ghose.

Navidea Biopharmaceuticals Inc. took a first step toward developing radioactive drugs to treat disease instead of just detect it with the formation of a joint venture with an early stage pharmaceutical company focused on arthritis.

Click here to read the complete article.

Originally published July 17, 2014.

Leave a Reply

This site uses Akismet to reduce spam. Learn how your comment data is processed.

%d bloggers like this: